|
|
.
ICD-10 (CM) Code and Descriptor
|
D49.0 |
Neoplasm of unspecified behavior of digestive system
|
D490 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 46.33%
|
19.31%
|
11.34%
|
7.07%
|
4.88%
|
3.21%
|
2.15%
|
1.53%
|
1.07%
|
0.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D49.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
5,622
|
5,639
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,463
|
3,479
|
|
74183
|
MRI ABD W/O CNTR FLWD CNTR |
3,295
|
3,296
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,544
|
2,544
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
2,385
|
230,702
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,187
|
2,189
|
|
G1004
|
CDSM NDSC |
2,031
|
2,174
|
|
82565
|
ASSAY OF CREATININE |
1,731
|
1,732
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,418
|
1,863
|
|
A9585
|
GADOBUTROL INJECTION |
1,274
|
86,972
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
1,266
|
1,266
|
|
86301
|
IMMUNOASSAY TUMOR CA 19-9 |
1,163
|
1,163
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,141
|
40,416
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
859
|
866
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
817
|
817
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
769
|
103,588
|
|
85027
|
COMPLETE CBC AUTOMATED |
672
|
672
|
|
71260
|
CT THORAX DX C+ |
643
|
643
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
632
|
713
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
622
|
2,323
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D49.0 related to the following DRG Codes:
374-376
|
